Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Effect of short-term sensitivity loss in LiF:Mg,Cu,P thermoluminescent dosemeter and its implications on personnel dosimetry operations.

Romanyukha A, Delzer JA, Grypp MD, Williams AS.

Radiat Prot Dosimetry. 2016 Feb;168(2):204-11. doi: 10.1093/rpd/ncv017. Epub 2015 Mar 11.

2.

Genomic Knockout of Endogenous Canine P-Glycoprotein in Wild-Type, Human P-Glycoprotein and Human BCRP Transfected MDCKII Cell Lines by Zinc Finger Nucleases.

Gartzke D, Delzer J, Laplanche L, Uchida Y, Hoshi Y, Tachikawa M, Terasaki T, Sydor J, Fricker G.

Pharm Res. 2015 Jun;32(6):2060-71. doi: 10.1007/s11095-014-1599-5. Epub 2014 Dec 19.

PMID:
25522789
3.

Disposition and drug-drug interaction potential of veliparib (ABT-888), a novel and potent inhibitor of poly(ADP-ribose) polymerase.

Li X, Delzer J, Voorman R, de Morais SM, Lao Y.

Drug Metab Dispos. 2011 Jul;39(7):1161-9. doi: 10.1124/dmd.110.037820. Epub 2011 Mar 24.

PMID:
21436403
4.

A fluorescence-based in vitro assay for drug interactions with breast cancer resistance protein (BCRP, ABCG2).

Mahringer A, Delzer J, Fricker G.

Eur J Pharm Biopharm. 2009 Aug;72(3):605-13. doi: 10.1016/j.ejpb.2009.01.010.

PMID:
19572416
5.

Long-term fade study of the DT-702 LiF: Mg,Cu,P TLD.

Delzer JA, Hawley JR, Romanyukha A, Nemmers S, Selwyn R, Benevides LA.

Radiat Prot Dosimetry. 2008;131(3):279-86. doi: 10.1093/rpd/ncn182. Epub 2008 Jul 11.

PMID:
18621919
6.

Design and synthesis of novel potent and selective integrin alphanubeta3 antagonists--novel synthetic routes to isoquinolinone, benzoxazinone, and quinazolinone acetates.

Seitz W, Geneste H, Backfisch G, Delzer J, Graef C, Hornberger W, Kling A, Subkowski T, Zimmermann N.

Bioorg Med Chem Lett. 2008 Jan 15;18(2):527-31. Epub 2007 Nov 28.

PMID:
18068982
7.

Synthesis and SAR of highly potent and selective dopamine D3-receptor antagonists: variations on the 1H-pyrimidin-2-one theme.

Geneste H, Amberg W, Backfisch G, Beyerbach A, Braje WM, Delzer J, Haupt A, Hutchins CW, King LL, Sauer DR, Unger L, Wernet W.

Bioorg Med Chem Lett. 2006 Apr 1;16(7):1934-7. Epub 2006 Jan 24.

PMID:
16439127
8.

Synthesis and SAR of highly potent and selective dopamine D(3)-receptor antagonists: 1H-pyrimidin-2-one derivatives.

Geneste H, Backfisch G, Braje W, Delzer J, Haupt A, Hutchins CW, King LL, Kling A, Teschendorf HJ, Unger L, Wernet W.

Bioorg Med Chem Lett. 2006 Feb;16(3):490-4. Epub 2005 Nov 11.

PMID:
16290141
9.

Synthesis and SAR of highly potent and selective dopamine D(3)-receptor antagonists: Quinolin(di)one and benzazepin(di)one derivatives. herve.geneste@abbott.com.

Geneste H, Backfisch G, Braje W, Delzer J, Haupt A, Hutchins CW, King LL, Lubisch W, Steiner G, Teschendorf HJ, Unger L, Wernet W.

Bioorg Med Chem Lett. 2006 Feb;16(3):658-62. Epub 2005 Nov 2.

PMID:
16271293
10.

Design and synthesis of 1,5- and 2,5-substituted tetrahydrobenzazepinones as novel potent and selective integrin alphaVbeta3 antagonists.

Kling A, Backfisch G, Delzer J, Geneste H, Graef C, Hornberger W, Lange UE, Lauterbach A, Seitz W, Subkowski T.

Bioorg Med Chem. 2003 Apr 3;11(7):1319-41.

PMID:
12628659
11.

Highly potent and selective alphaVbeta3-receptor antagonists: solid-phase synthesis and SAR of 1-substituted 4-amino-1H-pyrimidin-2-ones.

Zechel C, Backfisch G, Delzer J, Geneste H, Graef C, Hornberger W, Kling A, Lange UE, Lauterbach A, Seitz W, Subkowski T.

Bioorg Med Chem Lett. 2003 Jan 20;13(2):165-9.

PMID:
12482416
12.

Synthesis of highly potent and selective hetaryl ureas as integrin alpha(V)beta3-receptor antagonists.

Lange UE, Backfisch G, Delzer J, Geneste H, Graef C, Hornberger W, Kling A, Lauterbach A, Subkowski T, Zechel C.

Bioorg Med Chem Lett. 2002 May 20;12(10):1379-82.

PMID:
11992781
13.

Synthesis and SAR of N-substituted dibenzazepinone derivatives as novel potent and selective alpha(V)beta(3) antagonists.

Kling A, Backfisch G, Delzer J, Geneste H, Graef C, Holzenkamp U, Hornberger W, Lange UE, Lauterbach A, Mack H, Seitz W, Subkowski T.

Bioorg Med Chem Lett. 2002 Feb 11;12(3):441-6.

PMID:
11814816
14.

Production of human interferon-beta in mouse L-cells.

Delzer J, Hauser H, Lehmann J.

Dev Biol Stand. 1985;60:413-9.

PMID:
3899798
15.

New nikkomycins by mutasynthesis and directed fermentation.

Delzer J, Fiedler HP, Müller H, Zähner H, Rathmann R, Ernst K, König WA.

J Antibiot (Tokyo). 1984 Jan;37(1):80-2. No abstract available.

Supplemental Content

Loading ...
Support Center